Icro Meattini
@icromeattini.bsky.social
Professor, Florence University, Italy. Radiation/Clinical Oncologist. Head, Breast Unit at Florence Univ Hospital. Father. Opinions are my own. RT not endorse.
The #OncoAlertColloquium 2026 Breast Malignancies🚨 DAY TWO Presentation by Dr. Icro Meattini🇮🇹 Year in Review in #BreastCancer Radiation Therapy REGISTER HERE TO WATCH: buff.ly/OhocR7D In this presentation, Dr. Meattini highlights key practice-changing evidence from 2025 shaping modern breast RT ☢️
DAY TWO of the Colloquium Covering #BreastCancer Now Available On Demand!! Watch Here👉 vimeo.com/event/5689351 However it requires a password, to receive the password Register here👉 oncoalert.m-pages.com/7I0mwF/the-2... Year in Review in #BreastCancer brought to you by an amazing faculty
🌟 #ESTRO26 hits a new record! 🌟 4,091 abstracts submitted — over 500 more than last year! 🚀 Thank you to our incredible community! 💛Your research is what makes ESTRO the truly international hub of innovation in #radiotherapy. #ScientificExcellence #InnovationInCancerCare
See you all at #ASTRO25! #MedPhys #radoncsky
Fumiko Ladd Chino, MD FASCO@fumikochino.bsky.social · last yr.#ASTRO25 Storytelling Session Alert 🚨 Radiation Care and Survivorship in the Adolescent & Young Adult Cancer Population We will be discussing how to best care for #AYACSM including addressing their unique #AYAC survivorship needs 📆 Monday Sep29 ⏰5:00 - 6:00pm 📍Room 20/21
🎥 New video out! Excited to share the story of the IMPORTANT Project-the mission, clinical goals & innovative approach to optimizing CDK4/6-inhibitor treatment for older patients with advanced breast cancer ▶️ Watch the video: play.mediaflow.com/ovp/17/72DFN... 🔗 Learn more: important-project.com
📌 Opting Out of Therapy for Early-Stage Breast Cancer: How Far Might We Go? ✨Prof @icromeattini.bsky.social 👉🏻 How to Integrate Radiotherapy Into Current Treatment Concepts❗️ @oncoalert.bsky.social #OncoAlertAF #ASCO25 #RadOnc
Coming up today: Medical oncology/hematology fellow Dr. Emma Schatoff's poster session on "Risk factors associated with de novo metastatic colorectal cancer in early onset colorectal cancer" TODAY at the 2025 @ascocancer.bsky.social Annual Meeting. #ASCO25. 🗓️: 5/31 from 9-12pm CT
@cliffordhudis.bsky.social at #ASCO25: ~40% cut to NCI budget in Admin's '26 proposal. We are in a tragic paradox: remarkable science & historic cuts to resources needed to turn these opps into hope for millions of pts. Our advocacy, is more important than ever ➡️ brnw.ch/21wT3U4
Federal Funding for Cancer Research
As Congress negotiates Fiscal Year 2025 appropriations bills, urge them to make cancer research a top priority.
brnw.ch
The OncoAlert🚨ROUND UP Now Out‼️ Covering May 15-22, 2025 REGISTER at oncoalert360.com OR oncoalert.m-pages.com/nhMpwe/oncoa... youtu.be/xgIw0BISCpo @elisaagostinetto.bsky.social @barbaramelao.bsky.social @elisaagostinetto.bsky.social @icromeattini.bsky.social @realbowtiedoc.bsky.social
The OncoAlert Oncology Round Up May 15-22, 2025 Top Oncology Breakthroughs in less than 5 Min!
YouTube video by OncoAlert 360
youtu.be
The VJ OA Oncology Journal Club Dr. Evandro de Azambuja discussing APHINITY in #BreastCancer now on APPLE PODCASTS podcasts.apple.com/se/podcast/o... @elisaagostinetto.bsky.social @elisabettabonzano.bsky.social @icromeattini.bsky.social @maryamlustberg.bsky.social
VJ OA Oncology Journal Club: Final Results of the APHINITY Breast Cancer Trial Presented at ESMO Breast 2025
Poddavsnitt · OncoAlert · 2025-05-16 · 3 min
podcasts.apple.com
Hola #medsky #cansky #radonc #bcsm NRG Oncology is here👇🏻👇🏻 Give them a follow!
NRGOnc@nrgonc.bsky.social · last yr.May is National Cancer Research Month. Thanks to advances made by #cancer research, more than 18 million people in the US & millions more worldwide are living with, through, and beyond their disease. #UnitedByCancerResearch #NCRM25 Learn more: ow.ly/qNWq50VJ4Jk
Kicking Off ESTRO25: What’s Happening on Day 1 @estroradiotherapy.bsky.social @cancerphysicist.bsky.social @icromeattini.bsky.social @gerryhanna.bsky.social oncodaily.com/blog/estro25... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESTRO25 #ESTRO2025
Kicking Off ESTRO25: What’s Happening on Day 1 - OncoDaily
Kicking Off ESTRO25: What’s Happening on Day 1 / Aileen Duffton, Alizée Camps, Anamaria Girbovan, Ananya Choudhury, Ane Appelt, Beatson, Ben Heijmen,
oncodaily.com
✨We're thrilled to be taking part in #ESTRO25 in Vienna! EORTC researchers will be presenting cutting-edge findings in #RadiationOncology, a cornerstone of our scientific strategy. Find out more: www.eortc.org/blog/2025/05... @estroradiotherapy.bsky.social #CancerResearch
What a start , @mguckenberger.bsky.social with an emotional and inspiring talk at the opening Ceremony, Pascal Uffer delivered more than a talk ; if cancer were a start up. #ESTRO25 #radonc #radiotherapy
Thinking about your next move in #RadiationTherapy? Join us on May 15th for a free online info session and explore how our flexible, fully online postgrad programmes can help you specialise, lead, or innovate to reach your clinical and research goals. 📆 Register here: bit.ly/RadTherapy2025
Postgraduate MSc/Cert/Dip in Advanced Radiotherapy Practice - Open Evening
A fully online seminar to learn more about the Masters/Postgraduate Diploma/Certificate MSc in Advanced Radiotherapy Practice.
bit.ly
Planning Automation for Treatment Techniques Comparison and Robustness Analysis: Tangential IMRT and VMAT for Whole Breast Irradiation #BreastCancer #medphys #radonc #OncoAlert @oncoalert.bsky.social Free 50-day link: www.advancesradonc.org/article/S245...
Planning Automation for Treatment Techniques Comparison and Robustness Analysis: Tangential Intensity Modulated Radiation Therapy and Volumetric Modulated Arc Therapy for Whole Breast Irradiation
This study evaluates the use of the mCycle automated planning system integrated into the Monaco Treatment Planning System for step-and-shoot intensity modulated radiation therapy (IMRT) and volumetric...
advancesradonc.org
Planning Automation for Treatment Techniques Comparison and Robustness Analysis: Tangential IMRT and VMAT for Whole Breast Irradiation #BreastCancer #medphys #radonc #OncoAlert @oncoalert.bsky.social Free 50-day link: www.advancesradonc.org/article/S245...
Planning Automation for Treatment Techniques Comparison and Robustness Analysis: Tangential Intensity Modulated Radiation Therapy and Volumetric Modulated Arc Therapy for Whole Breast Irradiation
This study evaluates the use of the mCycle automated planning system integrated into the Monaco Treatment Planning System for step-and-shoot intensity modulated radiation therapy (IMRT) and volumetric...
advancesradonc.org
Long-Term Outcomes of #Radiation Monotherapy Versus Combined RT + Hormone Therapy in Low-Risk Early-Stage #BreastCancer Patients 70 Years or Older After Breast-Conserving Surgery @oncoalert.bsky.social #OncoAlert @ijrobp.bsky.social #radonc www.redjournal.org/article/S036...
Long-Term Outcomes of Radiation Monotherapy Versus Combined Radiation Monotherapy + Hormone Therapy in Low-Risk Early-Stage Breast Cancer Patients 70 Years or Older After Breast-Conserving Surgery
Standard therapy for breast cancer after breast-conserving surgery is radiation therapy (RT) plus hormone therapy (HT). For patients with a low-risk of recurrence, there is an interest in deescalating...
redjournal.org
📢 Just published! A phase II study of #abemaciclib for patients with #retinoblastoma-positive, triple-negative #metastatic breast cancer. 🔓https://pubmed.ncbi.nlm.nih.gov/39908010/ @drtimothyerick.bsky.social @nlinmd.bsky.social @stolaney1.bsky.social
Mechthild Krause, Prof.@mekrause.bsky.social · 2y agoHigher NTCP with variable RBE predictions in Proton RT of brain tumours- especially for blindness and deppendent in Patient factors. LET or track-end optimization can lower the risk. @hzdr.bsky.social @oncoalert.bsky.social www.sciencedirect.com/science/arti...
Day Three #OncoAlertColloquium 🚨 #BreastCancer REGISTER for FREE HERE👉 buff.ly/4gsEa2f prof @icromeattini.bsky.social 🇮🇹 👏🏻 Radiation Oncology in Breast Cancer: Year in Review @oncoalert.bsky.social
Congrats to all the new Fellows of @ascocancer.bsky.social especially Drs Arjun Gupta, @ryannipp.bsky.social, and @lymphomadoc.bsky.social 🙌🙌🙌 Excited to be in your FASCO class and celebrate with you in Chicago this year. 🥳
Day3⃣ #OncoAlertColloquium 🚨 #BreastCancer REGISTER for FREE HERE👉 https://buff.ly/3Q6ttHY @Icro_Meattini 🇮🇹 Radiation Oncology in Breast Cancer: Year in Review REGISTER NOW for a Live chat with Dr. Meattini @icromeattini.bsky.social @elisaagostinetto.bsky.social @elisabettabonzano.bsky.social
United in our goals - equity of access for all our patients #WorldCancerDay #radonc #medonc #breastcancer #OncoAlert @oncoalert.bsky.social
Sot është Dita Botërore e Kancerit #WorldCancerDay ditë që na bashkon në luftën për një të ardhme më të mirë për pacientët me kancer në Shqipëri dhe kudo në botë🧡 Kjo nuk është vetëm një betejë për trajtim – është një betejë për dinjitet, për jetë dhe për një të ardhme më të drejtë për të gjithë!
CNS metastases are the main challenge in HER2+ breast cancer - Nelson Moss @mskcancercenter.bsky.social oncodaily.com/blog/nelson-... #BreastCancer #Cancer #MemorialSloanKettering #Health #OncoDaily #Oncology #Medicine
Nelson Moss: CNS metastases are the main challenge in HER2+ breast cancer - OncoDaily
Nelson Moss: CNS metastases are the main challenge in HER2+ breast cancer / Anne S. Reiner, Breast Cancer, cancer, Emanuela Ferraro, Nelson Moss, Neurosurgery
oncodaily.com
🌍 This #WorldCancerDay, we celebrate progress and innovation in the fight against cancer. Discover the groundbreaking advancements shaping oncology in 2024, from immunotherapy to personalised medicine. 💡🔬 Read more: https://buff.ly/3Ewkmha #Oncology #CancerResearch
2024 Clinical breakthroughs in Oncology - VJOncology
As 2024 comes to a close, it is essential to recognize the remarkable progress and ground-breaking achievements that have redefined...
buff.ly
